Liénard, Danielle <br/><br/>
Ex vivo detectable activation of Melan-A-specific T cells correlating with inflammatory skin reactions in melanoma patients vaccinated with peptides in IFA.  [electronic resource] 

 -  Cancer immunity  May 2004 
 - 4 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1424-9634 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antigens, Neoplasm<br/>CD8-Positive T-Lymphocytes--immunology<br/>Cancer Vaccines--immunology<br/>Dermatitis--etiology<br/>Disease Progression<br/>Female<br/>Freund's Adjuvant--therapeutic use<br/>Humans<br/>Lipids--therapeutic use<br/>Lymphocyte Activation<br/>MART-1 Antigen<br/>Male<br/>Melanoma--diagnosis<br/>Middle Aged<br/>Monitoring, Immunologic<br/>Neoplasm Proteins--immunology<br/>Peptides--immunology<br/>Viral Matrix Proteins--immunology